Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afabicin vs Vancomycin/Linezolid in ABSSSI
NCT02426918Phase 2Completed
- Sponsor
- Debiopharm
- Start
- May 2015
- Primary completion
- Aug 2016
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of afabicin in acute bacterial skin and skin structure infections (ABSSSI), sponsored by Debiopharm. Started May 2015; status: completed.
02
Drugs
afabicin
03
Conditions
acute bacterial skin and skin structure infections (ABSSSI)
Beyond the preview
Go deeper on NCT02426918.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02426918.